Journey Medical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DERM and other ETFs, options, and stocks.

About DERM

Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. 

CEO
Claude Maraoui
CEOClaude Maraoui
Employees
41
Employees41
Headquarters
Scottsdale, Arizona
HeadquartersScottsdale, Arizona
Founded
2014
Founded2014
Employees
41
Employees41

DERM Key Statistics

Market cap
296.99M
Market cap296.99M
Price-Earnings ratio
-25.22
Price-Earnings ratio-25.22
Dividend yield
Dividend yield
Average volume
153.56K
Average volume153.56K
High today
$9.55
High today$9.55
Low today
$8.93
Low today$8.93
Open price
$9.21
Open price$9.21
Volume
120.87K
Volume120.87K
52 Week high
$9.55
52 Week high$9.55
52 Week low
$3.63
52 Week low$3.63

Stock Snapshot

Journey Medical(DERM) stock is priced at $8.93, giving the company a market capitalization of 296.99M. It carries a P/E multiple of -25.22.

During the trading session on 2026-01-23, Journey Medical(DERM) shares reached a daily high of $9.55 and a low of $8.93. At a current price of $8.93, the stock is 0.0% higher than the low and still -6.5% under the high.

Trading activity shows a volume of 120.87K, compared to an average daily volume of 153.56K.

Over the past 52 weeks, Journey Medical(DERM) stock has traded between a high of $9.55 and a low of $3.63.

Over the past 52 weeks, Journey Medical(DERM) stock has traded between a high of $9.55 and a low of $3.63.

People also own

Based on the portfolios of people who own DERM. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.